Andrea G. Buchwald, PhD

2004 - 2008: BA Mathematics, Biology, The Colorado College

2013 - 2018: PhD Epidemiology, University of Maryland School of Medicine (Advisor: Miriam K. Laufer)

2018 - 2020: Postdoctoral Fellow, Department of Environmental and Occupational Health, Colorado School of Public Health (Mentor: Elizabeth J. Carlton)

2020 - 2021: Research Associate, Department of Biostatistics and Informatics, Colorado School of Public Health

Dr. Buchwald is an infectious disease epidemiologist with long-term interests in infection transmission, the impacts of climate change on infectious diseases, maternal-child health,  and using immunological data to inform intervention design. Her research largely focuses on the design and conduct of observational research to understand, detect, and control infectious diseases in low-resource settings.

Dr. Buchwald has expertise in the design, implementation, data collection, and data analysis for longitudinal cohort studies examining infectious disease incidence and the development of immunity. She has recently focused on developing techniques to monitor the SARS-CoV-2 pandemic, including developing models and metrics to advise public-policy makers, as well as developing methods to incorporate large scale behavioral, immunological, and epidemiological data into mathematical models. 

Dr. Buchwald's current research focuses on climate and health, immunological predictors of infant health, and the impact of in utero exposure to infections on long-term child health and development. 

Buchwald AG, Graham BS, Traore A, Haidara FC, Chen M, Morabito K, Lin BC, Sow SO, Levine MM, Pasetti MF, Tapia MD. Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life. Clin Infect Dis. 2021 Dec 6;73(11):e4421-e4427. doi: 10.1093/cid/ciaa648. PubMed PMID: 32463443; PubMed Central PMCID: PMC8662775.

Ndungo E, Andronescu LR, Buchwald AG, Lemme-Dumit JM, Mawindo P, Kapoor N, Fairman J, Laufer MK, Pasetti MF. Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis. Front Immunol. 2021;12:725129. doi: 10.3389/fimmu.2021.725129. eCollection 2021. PubMed PMID: 34721387; PubMed Central PMCID: PMC8554191.

Buchwald AG, Bayham J, Adams J, Bortz D, Colborn K, Zarella O, Buran M, Samet J, Ghosh D, Herlihy R, Carlton EJ. Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA. Emerg Infect Dis. 2021 Sep;27(9):2312-2322. doi: 10.3201/eid2709.204167. Epub 2021 Jun 30. PubMed PMID: 34193334; PubMed Central PMCID: PMC8386789.

Laufer RS, Driscoll AJ, Baral R, Buchwald AG, Campbell JD, Coulibaly F, Diallo F, Doumbia M, Galvani AP, Haidara FC, Kotloff KL, Keita AM, Neuzil KM, Orenstein EW, Orenstein LAV, Pecenka C, Sow S, Tapia MD, Ortiz JR, Fitzpatrick MC. Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions. Vaccine. 2021 Aug 16;39(35):5037-5045. doi: 10.1016/j.vaccine.2021.06.086. Epub 2021 Jul 26. PubMed PMID: 34325934; PubMed Central PMCID: PMC8377743.

Buchwald AG, Grover E, Van Dyke J, Kechris K, Lu D, Liu Y, Zhong B, Carlton EJ. Human Mobility Associated With Risk of Schistosoma japonicum Infection in Sichuan, China. Am J Epidemiol. 2021 Jul 1;190(7):1243-1252. doi: 10.1093/aje/kwaa292. PubMed PMID: 33438003; PubMed Central PMCID: PMC8245870.

Joannides J, Dzodzomenyo M, Azerigyik F, Agbosu EE, Pratt D, Nyarko Osei JH, Pwalia R, Amlalo GK, Appawu M, Takashi H, Iwanaga S, Buchwald A, Rochford R, Boakye D, Koram K, Bonney K, Dadzie S. Species composition and risk of transmission of some Aedes-borne arboviruses in some sites in Northern Ghana. PLoS One. 2021;16(6):e0234675. doi: 10.1371/journal.pone.0234675. eCollection 2021. PubMed PMID: 34061882; PubMed Central PMCID: PMC8168856.